Allianz Asset Management
IDYA icon

Allianz Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Allianz Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Buy
+20,000
New +$612K ﹤0.01% 1940
2024
Q4 		– Sell
-12,400
Closed -$393K – 2267
2024
Q3 		$393K Buy
12,400
+2,600
+27% +$98.6K ﹤0.01% 1914
2024
Q2 		$344K Sell
9,800
-5,100
-34% -$202K ﹤0.01% 1935
2024
Q1 		$654K Sell
14,900
-4,900
-25% -$211K ﹤0.01% 1534
2023
Q4 		$704K Hold
19,800
– – ﹤0.01% 1737
2023
Q3 		$534K Sell
19,800
-5,700
-22% -$145K ﹤0.01% 1898
2023
Q2 		$599K Buy
+25,500
New +$524K ﹤0.01% 1688

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Allianz Asset Management's IDYA Position: Q2 2026 in Review

Allianz Asset Management opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 20,000 shares worth $745K. The stake represents ﹤0.01% of the portfolio and ranks #1940 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in IDYA as recently as Q3 2024.

Allianz Asset Management first reported a position in IDYA in Q2 2023 and has held it in 7 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Allianz Asset Management held 20,000 shares of IDEAYA Biosciences worth $745K as of Q2 2026.
  • IDEAYA Biosciences was a new Allianz Asset Management position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1940 holding.
  • Allianz Asset Management first reported a position in IDEAYA Biosciences in Q2 2023 and has held it in 7 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.